bioMérieux
Zack Blair has a diverse work experience in the field of microbiology and clinical science. ZACK is currently working as the Senior Vice President R&D Microbiology at bioMérieux, where they previously held the position of Vice President Research Development-MICROBIOLOGY Portfolio. ZACK has also served as a Program Director for Microbiology - Mass Spectrometry and as the Global Customer Support Manager - Clinical Unit at bioMérieux. Prior to joining bioMérieux, Zack worked as a Microbiologist at SSM Health St. Louis. ZACK also has experience as a Clinical Scientist at Breckinridge Memorial Hospital/Nursing, PCMH Hospital, and Owensboro Health.
Zack Blair has a Bachelor's Degree in Biology, Clinical Laboratory Science/Medical Technology/Technologist from Brescia University. ZACK also holds a Master of Health Administration from Webster University, obtained between 2012 and 2014. Currently, they are pursuing a Doctoral Degree in Public Health (DrPH) from Walden University. In addition, they have received certification from the American Society for Clinical Pathology (ASCP). ZACK has also completed an executive leadership program at CEDEP - Executive Development – Fontainebleau in 2019. There is no information available regarding their educational experience at the Pasteur Institute.
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.